Page last updated: 2024-08-17

levodopa and Dysautonomia

levodopa has been researched along with Dysautonomia in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Aridon, P; Arnao, V; ButtĂ , C; Cinturino, A; D'Amelio, M; Maida, C; Mastrilli, S; Tuttolomondo, A1
Borden, A; Bourre, B; Brun, L; Derrey, S; Fetter, D; Lefaucheur, R; MaltĂȘte, D; Wallon, D1
Artusi, CA; Comi, C; Duker, AP; Espay, AJ; Lanotte, M; Lopiano, L; Maule, S; Merola, A; Romagnolo, A; Rosso, M; Zibetti, M1
Maertens de Noordhout, A1
Cha, DR; Kang, YS; Koh, SB; Kwon, DY; Park, KW; Park, MH; Seo, WK1
Barichella, M; Caccialanza, R; Cancello, R; Cassani, E; Cereda, E; Iorio, L; Madio, C; Pezzoli, G; Pusani, C1

Reviews

1 review(s) available for levodopa and Dysautonomia

ArticleYear
[Management of Parkinson's disease in 2009].
    Revue medicale suisse, 2009, Aug-26, Volume: 5, Issue:214

    Topics: Antiparkinson Agents; Deep Brain Stimulation; Dopamine Agonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Primary Dysautonomias; Prognosis; Risk Factors

2009

Other Studies

5 other study(ies) available for levodopa and Dysautonomia

ArticleYear
Impaired circadian heart rate variability in Parkinson's disease: a time-domain analysis in ambulatory setting.
    BMC neurology, 2020, Apr-23, Volume: 20, Issue:1

    Topics: Aged; Antiparkinson Agents; Cardiovascular Diseases; Circadian Rhythm; Heart Rate; Humans; Levodopa; Middle Aged; Parkinson Disease; Pilot Projects; Primary Dysautonomias

2020
Non-motor fluctuations in Parkinson's disease: prevalence, characteristics and management in a large cohort of parkinsonian outpatients.
    Clinical neurology and neurosurgery, 2014, Volume: 127

    Topics: Age Factors; Aged; Antiparkinson Agents; Case Management; Cross-Sectional Studies; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Primary Dysautonomias

2014
Prevalence and burden of dysautonomia in advanced Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2017, Volume: 32, Issue:5

    Topics: Activities of Daily Living; Antiparkinson Agents; Carbidopa; Cross-Sectional Studies; Deep Brain Stimulation; Drug Combinations; Female; Humans; Levodopa; Logistic Models; Male; Parkinson Disease; Prevalence; Primary Dysautonomias; Severity of Illness Index; Subthalamic Nucleus; Surveys and Questionnaires

2017
Rapidly deteriorating parkinsonism and dysautonomia in patient with central pontine and extrapontine myelinolysis.
    Clinical neurology and neurosurgery, 2011, Volume: 113, Issue:6

    Topics: Antiparkinson Agents; Blood Pressure; Fatal Outcome; Gait Disorders, Neurologic; Humans; Hyponatremia; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Myelinolysis, Central Pontine; Parkinson Disease; Primary Dysautonomias; Psychomotor Agitation

2011
Nutritional risk and gastrointestinal dysautonomia symptoms in Parkinson's disease outpatients hospitalised on a scheduled basis.
    The British journal of nutrition, 2013, Jul-28, Volume: 110, Issue:2

    Topics: Aged; Confidence Intervals; Constipation; Deglutition Disorders; Female; Gastrointestinal Diseases; Hospitalization; Humans; Levodopa; Male; Malnutrition; Middle Aged; Nutritional Status; Odds Ratio; Outpatients; Parkinson Disease; Prevalence; Primary Dysautonomias; Risk Factors; Severity of Illness Index; Sialorrhea; Weight Loss

2013